Klaria Pharma Holding AB: Klaria accelerates its business development work in collaboration with BDO
With Klaria's product, Sumatriptan Alginate Film, approved in the EU and set to launch in 2026 in the largest EU markets, the company has now engaged BDO LLP's UK Life Sciences & Healthcare M&A team ( ...
Dr Reddy's Laboratories launched the drug in US market which is going to show some amount of incremental momentum for the US market. They have launched Sumatriptan Injection USP, which is an ...
Klaria announced earlier in the year that it had submitted an additional patent application on the sumatriptan oral film product to further protect the product and potentially extend its market ...
Berlin - Die gesundheitliche Belastung ist für sie ein ständiger Begleiter: Linken-Fraktionschefin Heidi Reichinnek (37) ...
Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...
Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Sumatriptan Injection ...
Wie wirkt der Inhaltsstoff des Arzneimittels? Der Wirkstoff tritt mit speziellen Bindungsstellen im Körper, den sog. 5HT-1-Rezeptoren, in Kontakt. Durch diesen Kontakt werden folgende Reaktionen ...
mindestens 14 Tagen Länge gekommen ist, spricht man von einem chronischen Clusterkopfschmerz. Es ist möglich, daß ein chronischer Clusterkopfschmerz bereits von Beginn an diesen nicht durch freie ...
• Robust efficacy versus vehicle at 1 and 2 hours in both sexes (periorbital von Frey thresholds). • Benchmark comparison: BMB‑201 showed greater effect sizes than sumatriptan at multiple timepoints ...
Detectives found prescription medication for depression and epilepsy in the Las Vegas home of Midtown mass shooter Shane Tamura, sources tell The Post. The discovery was made while executing a search ...
Berlin. Das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) hat im Zusammenhang mit der Bewertung von regelmäßig aktualisierten Berichten zur Unbedenklichkeit von Arzneimitteln drei ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results